Cel Sci (CVM) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026)
Cel Sci (CVM) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 24.71% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.77% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -99.85% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -5.07% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.70% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 10.87% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 70.79% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 19.14% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cel Sci | 2.12 Mn | -4.42 Mn | - | -30.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.38% |
| Dec 31, 2025 | -26.63% |
| Sep 30, 2025 | -25.22% |
| Jun 30, 2025 | -23.62% |
| Mar 31, 2025 | -22.31% |
| Dec 31, 2024 | -21.27% |
| Sep 30, 2024 | -20.20% |
| Jun 30, 2024 | -19.31% |
| Mar 31, 2024 | -18.48% |
| Dec 31, 2023 | -16.29% |
| Sep 30, 2023 | -14.31% |
| Jun 30, 2023 | -13.87% |
| Mar 31, 2023 | -13.14% |
| Dec 31, 2022 | -13.31% |
| Sep 30, 2022 | -12.99% |
| Jun 30, 2022 | -8.52% |
| Mar 31, 2022 | 2.15% |
| Dec 31, 2021 | 41.36% |
| Sep 30, 2021 | 133.81% |
| Jun 30, 2021 | 260.07% |